Understand how we got here — and how to move forward.



Why and how to address health disparities in lung cancer detection

November 4, 2021

3:00 PM - 4:00 PM EDT

    Session Overview

    Leaders across the health care industry recognize the need to address inequities in health care but often struggle to make progress. We see disparities in lung cancer screening and, subsequently, cancer outcomes persist. For example, lung cancer mortality is highest among Black men, and five-times higher among the least educated men compared to the highest educated men. Women also have a higher incidence of lung cancer than men.

    In this session, we will convene an expert panel to discuss the underlying challenges with inequity in lung cancer care, learn from their experiences, and offer opportunities to meaningful reduce disparities in lung cancer detection.

    Facilitated by Advisory Board’s Deirdre Saulet, the panel represents perspectives across the lung cancer ecosystem:

    • Dr. Efren Flores, Officer for Radiology Community Health & Equity, Massachusetts General Hospital
    • Dr. Ann Taylor, former Chief Medical Officer, AstraZeneca
    • Solomon Banjo, Managing Director at Advisory Board, senior researcher diversity in clinical trials and similar topics

    Things you’ll learn:

    • Root causes of inequity and health disparities within lung cancer detection
    • Opportunities and strategies to address inequity in lung cancer screening and detection
    • How leaders in the field have taken action to mitigate health disparities related to lung cancer detection

    Presenters: Deirdre Saulet, Solomon Banjo, Dr. Ann Taylor, and Dr. Efren Flores

    Sponsored by
    The Lung Ambition Alliance logo

    About the Sponsor

    The Lung Ambition Alliance, a global coalition with partners across disciplines in over 50 countries, was formed to combat lung cancer through accelerating innovation and driving forward meaningful improvements for people with lung cancer. We do this by advocating for improved approaches in three areas: screening and early diagnosis, accelerated delivery of innovative medicine, and improved quality care.

    Learn more about The Lung Ambition Alliance

    This webinar is sponsored by AstraZeneca for educational purposes only. The content, views, and opinions contained within the webinar are copyrighted by Advisory Board and all rights are reserved. Advisory Board experts wrote the content, conducting the underlying research independently and objectively. Advisory Board does not endorse any company, organization, product or brand mentioned herein.

    View Advisory Board's editorial guidelines

    Have a Question?


    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.